Market sharing infringement was correctly proven, says CMA counsel
The UK’s antitrust authority has pushed back against members of the Prochlorperazine cartel that claim it failed to meet the burden of proof when levying fines in 2022, telling the Competition Appeal Tribunal that their defence relies on several improbable coincidences and mistakes.
To read more
Subscribe to Global Competition Review
Subscribe to unlock unlimited access
Get news, unique commentary, expert analysis and essential resources from the Global Competition Review experts.